Private Equity

Cannara Biotech rockets to #1 in Québec's cannabis market, fueled by a smash-hit vape launch, while also moving to overhaul its corporate governance.

Following the sale of its legacy business, the newly-rebranded Accendra Health launches on the NYSE with a laser focus on the booming home healthcare market.

The strategic separation of MarathonLS into two specialized firms aims to boost growth and service in the competitive life sciences support sector.

As INCERGO finalizes its Visual Semiconductor merger, it's betting on GF3D™ tech to revive 3D displays. Can it succeed where 3D TVs failed?

Neovii Pharmaceuticals names Frédéric Prince its next CEO, bringing deep oncology and gene therapy experience from Roche to steer its next growth phase.

Distressed debt giant Silver Point Capital acquires a controlling interest in claims against bankrupt auto parts maker First Brands, a strategic move.

The MICE giant's massive government contract to manage a 185,000-pilgrim yatra signals a strategic shift and a new model for public-private partnerships.

World No.1 table tennis star Sun Yingsha joins La Roche-Posay in a strategic play for Gen-Z hearts and the massive Asian beauty market.

With a 79% drop in net loss and a fourth straight growth quarter, supplement maker Vitality Products Inc. bets on new hires to conquer online and retail.

Vivakor blames a government shutdown for its dividend delay, but shareholders are left grappling with an unusual asset and a complex CEO-related deal.

All eyes are on Sandisk's Jan 29 report. Can the reborn flash memory leader meet lofty expectations and prove its post-spin-off strategy is a success?

ECN Capital urges shareholders to approve a C$1.9 billion takeover by Warburg Pincus, offering a 13% premium and a shift to private ownership.

Interim CFO Donna Granato's departure marks a pivotal moment for Ayr Wellness as it completes a massive debt restructuring and transitions to a new entity.

Euromax Resources raised C$1.6M, but with 84% for overhead and only 9% for its stalled gold project, is this a step forward or just staying afloat?

Privately held MMMera hires strategic firm CND-SA to scale its Guillotine® gaming IP, a move highlighting the high-stakes game of professionalizing art.

Facing a Nasdaq delisting threat, China-based WF International has 180 days to revive its stock after a dramatic collapse since its April IPO.

Italian luxury knitwear maker Zanieri completes a reverse merger with Everlert, Inc., gaining a US public listing to fund global expansion and brand growth.

After a year of major acquisitions and AI-driven innovation, all eyes are on Labcorp's strategic vision for 2026 at the J.P. Morgan Healthcare Conference.

Treace Medical heads to the J.P. Morgan conference to showcase its surgical tech, facing tough questions on growth amid competition and market shifts.

INVO Fertility realigns its top brass, positioning a deal-making veteran to lead an aggressive clinic acquisition strategy in a booming market.